Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Visit the fictional town of Deficiency, Maine, where primary immunodeficiencies affecting both B and T cells are explored through a captivating narrative. The scene is set during summer…
Learn about the specifics of treating non-small cell lung cancer (NSCLC) when a KRAS mutation is present. The KRAS gene, often mutated in several cancers including NSCLC, signals…
Ed Overfield shares his personal battle with non-small cell lung cancer, a journey marked by the loss of his mother to the same disease and his own diagnosis…
In this episode of “Ask a Nurse,” Kathy from Level Up RN discusses ulcerative colitis, a chronic inflammatory bowel disease. She explains its symptoms, including diarrhea, blood in…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…
This presentation delves into the pathophysiology of CML, highlighting its progression from the chronic phase through the accelerated phase to the blast phase.…
Rajdeep Mysore, MD discusses melanoma, the most dangerous type of skin cancer. Originating from melanocytes, the color-producing cells in the skin, melanomas often appear as black or brown…
This presentation delves into the pathophysiology of CML, highlighting its progression from the chronic phase through the accelerated phase to the blast phase.
Emma, a person who has IgA nephropathy, discusses her experience with diagnosis and treatment. She also discusses the importance of communication with medical professionals and she recommends avoiding…
